Tissue Regenix receives US patent for bladder implants Proactive Investors UK Antony Odell, Tissue Regenix’s chief executive, said: “This latest patent adds to our fast-growing global portfolio, and will allow Tissue Regenix to use our dCELL…
See on www.proactiveinvestors.co.uk
Kenneth Carnesi holds a Juris Doctor degree from New York Law School and a Professional Certificate in International Banking from Harvard Law School. Kenneth Carnesi is the Director of Operations and Government Sales at Anaptyx LLC and sits on the Boards of The Lazarus Organization, Monkeetech LLC and MG Madison Phillips, Inc. Mr. Carnesi has also founded CICG - Carnesi International Consulting Group, a company specializing in strategy consulting to small to mid-size businesses.
Kenneth Carnesi 
Leave a comment